Antonio Chiesi
Experienced Pharma/Biotech Executive
Biotech and Pharma
EXOSOMICS SIENA S.p.A.
Italy
Biography
Founder (2011) and CEO a biotech Company based in Italy (Exosomics Siena SpA) engaged in validation and clinical development of new and disruptive exosome based in vitro diagnostic assays with a major focus on cancer. Exosomics Siena (EXS) is a spin out Company of HansaBioMed and takes advantage of the IP and KH developed by its mother Company. EXS' mission is to bring to the market place, within five years from its establishment, a new generation of IVD for cancer diagnostics and new tools for companion diagnostics and stratified medicine in oncology.
Research Interest
pecialties: Wide experience in clinical development of drugs and IVD. Projects and programs management as team leader. Experience in Clinical Research management (planning and executive activities including regulatory procedures and auditing). Experience in IPR protection and technology transfer. Experience in start ups and investors relations in the biotech area. Therapeutic Areas: HIV infection, Oncology, Neurodegeneration, Psychiatry, Cardiovascular.
